Kristy Como in

Kristy Como

Login to view DISC.
Executive Business Director - Alzheimer's Disease at Eisai US
📍 New York City Metropolitan Area, United States

Kristy Como is the Executive Business Director for Alzheimers Disease at Eisai US, bringing extensive experience in pharmaceutical commercial leadership. Her background includes directing large sales and marketing teams at companies like Medtronic and Actavis. She holds a Bachelor of Business Administration from UMass Amherst.

She has a recognized passion for team development, stemming from her previous role as Senior Director of Commercial Training & Development. Colleagues describe her as an authentic, accountable, and tenacious leader.

In 2018, Kristy was honored with the Healthcare Businesswomens Association (HBA) Rising Star award for her leadership and unwavering commitment to patients.

Read the full overview →
Experience
14 Years
Current Role
Executive Business Director - Alzheimer's Disease
Job Level
Senior
Location
New York City Metropolitan Area, United States
Personality Overview

How Kristy shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Kristy cares about

Alzheimer's Disease
Her current executive role is dedicated to leading the commercial business for Eisai's Alzheimer's Disease franchise.
Commercial Leadership
She has a history of leading large commercial teams, including managing over 100 sales employees in a previous role at Actavis.
+4 more topics Login to view topics
Career

Work history

1-2023
Executive Business Director - Alzheimer's Disease
Eisai US
9-2020 - 4-2023
Executive Director, Epilepsy Sales & Marketing
Eisai US
3-2020 - 9-2020
Senior Director, Commercial Training & Development
Eisai US
4-2015 - 12-2016
District Sales Manager at Medtronic Diabetes
Medtronic
4-2013 - 4-2015
Regional Sales Director
Actavis ( Formerly Forest Pharmaceuticals)
In the press

Media appearances

Eisai Publishes Potential Economic Value of Investigational Lecanemab in Peer‑Reviewed Neurology and Therapy Journal. Featured in Eisai US Newsroom
See now
Alzheimer's Disease innovation by prioritizing patients. Featured in Eisai US
+1 more appearances Login to view media
Education
1995 - 1999
Bachelor of Business Administration (B.B.A.)
Isenberg School of Management, UMass Amherst
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Eisai US Employees

Explore more public profiles from related professionals.

Karen Connolly
Karen Connolly
Commercial Training and Development
Eisai US
 Michael Nelson
Michael Nelson
Director, Health Economics and Outcomes Research and RWE
Eisai US

More profiles

Discover additional public profiles from our index.

Brett Crockett
Brett Crockett
Board Member - Bay Area Science and Innovation Consortium (BASIC)
Bay Area Council
 Sean Flanagan
Sean Flanagan
Senior Vice President of Sales
Blueprint Medicines
 Bo Grmoljez
Bo Grmoljez
Vice President Sales, West
Blueprint Medicines
 Muhammad Danish Azhar
Muhammad Danish Azhar
Director of Operations
GRS Technology Solutions
Unlock the full playbookSee exactly how to sell to Kristy. Free, 10 seconds.